SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mirror Image who wrote (1853)4/16/2016 4:06:12 PM
From: Strong Long   of 2026
 
Thanks MI, I'll take circumstantial right now. You are correct, IR never got back to me. Missing David Collins for sure. I really hope Sandoz has returned to making vitaros available.

While on the topic of Tweets, I see that our French Urologist friend DR. Vincent Huppertan tweeted out a couple more Vitaros tweets last week. Using google translate, I believe what he was saying about Vitaros in his tweets were:

1) It is not dangerous to have oral sex when using Vitaros.

2) It is safe to have unprotected sex when using Vitaros...from a partner exposure stand point.

As time goes on, DR. Huppertan seems to be generating and sharing some of the most useful information about Vitaros use. He also encourages patients to try multiple applications if results are not experienced when first trying it. Interestingly, in the article I forwarded on SI last week, it spoke of how concentration of DDAIP can build up in the skin over time...I've wondered if this has anything to do with the possibility that Vitaros can become more effective after multiple uses. That point (my point), however, seems to be inconsistent with other Vitaros user experiences, where individuals have said they can sometimes achieve an erection without an application...the thought being, there must be something else at work, since the active ingredient Alprostadil is not present in that case.

As Apricus continues to tweek product storage and application to make it more attractive to users, and with the possibility to get back in the US market, the potential for Vitaros is still there. Sure seems a long way away, but if APRI can in fact be profitable next year, the pps should crawl out it's ugly little hole.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext